Borel J P, Bellon G, Garnotel R, Monboisse J C
Laboratory of Biochemistry, URA CNRS 610, University of Reims, France.
Kidney Int. 1993 Jan;43(1):26-9. doi: 10.1038/ki.1993.6.
In a previous study, we found that type I collagen activates human polymorphonuclear neutrophils by binding to a membrane integrin [3]. The activation depends on two sequences, both contained in the alpha 1 (I) CB6 peptide, one is RGD, starting at residue 915, and the second is DGGRYY, starting at residue 1034 of the alpha 1(I) chain. We checked the effect of several other types of collagens, principally type IV collagen from several origins. The basement membrane from bovine lens as well as type IV collagen prepared from it by tartaric acid extraction did not activate the human neutrophils. In contrast, when neutrophils had been previously in contact with type IV collagen their activation by type I or the alpha 1(I) CB6 peptide, or the bacterial peptide N-formyl-methionyl-leucyl-phenylalanine, was inhibited. This effect was abolished when type IV collagen had been previously treated by pepsin. On the other hand, the fractions of type IV collagen that resisted digestion by bacterial collagenase still exhibited this inhibiting effect. This effect probably explains the physiological property of neutrophils to cross vascular walls without being activated.
在先前的一项研究中,我们发现I型胶原通过与膜整合素结合来激活人多形核中性粒细胞[3]。这种激活取决于两个序列,二者均包含在α1(I)CB6肽中,一个是位于915位残基处开始的RGD,另一个是位于α1(I)链1034位残基处开始的DGGRYY。我们检测了其他几种类型胶原的作用,主要是来自几个来源的IV型胶原。牛晶状体的基底膜以及通过酒石酸提取从中制备的IV型胶原均未激活人中性粒细胞。相反,当中性粒细胞先前已与IV型胶原接触时,它们被I型或α1(I)CB6肽或细菌肽N-甲酰甲硫氨酰亮氨酰苯丙氨酸激活的过程受到抑制。当IV型胶原先前用胃蛋白酶处理时,这种作用就消失了。另一方面,抵抗细菌胶原酶消化的IV型胶原部分仍然表现出这种抑制作用。这种作用可能解释了中性粒细胞在不被激活的情况下穿过血管壁的生理特性。